-
HER2-targeting Peptide Drug Conjugate with Better Penetrability for Effective Breast Cancer Therapy
Announcing a new article publication for BIO Integration journal. Antibody-drug conjugates (ADCs) have the following advantages: target specificity; wide therapeutic index; and prolonged circulation half-life. A key limitation of ADCs,…
-
Integration of Reactive Oxygen Species Generation and Prodrug Activation for Cancer Therapy
Announcing a new article publication for BIO Integration journal. In this article the authors Xiao’en Shi, Xu Zhang, Xinlu Zhang, Haizhen Guo and Sheng Wang from Tianjin University, Tianjin, China…
-
Theranostics in Cancer Therapy: Integration for Transformative Research
In this short video extract Professor Phei Er Saw, Executive Editor, BIOI, introduces a presentation from Dr Xiaoyuan (Shawn) Chen, National Institutes of Health, Bethesda, MD, USA, on Theranostics in…
-
Nanobiohybrids: A Synergistic Integration of Bacteria and Nanomaterials in Cancer Therapy– BIO Integration
Announcing a new article publication for BIO Integration journal. In this mini review article the authors Yuhao Chen, Meng Du, Jinsui Yu, Lang Rao, Xiaoyuan Chen and Zhiyi Chen from…